Advancing Discovery Through Translational Preclinical CRO Services
We leverage a validated portfolio of preclinical assays and in vivo disease models backed by recognized expertise in immunology and infectious diseases to support preclinical-stage drug discovery and development.
TICRO scientists partner with clients to de-risk the biology. Our scientific team designs custom preclinical studies that address complex disease questions, reduce scientific uncertainty and position you to receive high-quality data to better inform decision making before advancing to the clinic.
In Vivo Models
In vivo animal models facilitate evaluation of the effectiveness of new drugs, vaccines and/or therapeutic regimens as well as their potential to affect immune cell responses to infection. Our small animal platform is well suited for efficacy testing, proof of concept studies and generating mechanistic insights.
Diagnostic Assays
TICRO boasts qualified, highly trained personnel combined with access to state-of-the-art facilities, including Immunohistochemistry, Flow Cytometry, Microscopy and Imaging and Molecular Biology Core Facilities, to meticulously conduct experiments and in vitro/ex vivo assays according to study specifications.
Injections & Surgery
Our in vivo models facilitate the study of the pathogenesis and complications of immune-mediated and infectious diseases, and permit preclinical evaluations of treatment protocols as a precursor to clinical studies.